Related Experiment Videos
A study of bone proteins which can prevent hydroxyapatite formation
Metabolic Bone Disease & Related Research
|January 1, 1982
Summary
Noncollagenous bone proteins inhibit calcium phosphate precipitation. Osteocalcin and osteonectin show similar activity, but osteonectin is more potent per molecule, regulating bone mineral solubility.
Area of Science:
- Biochemistry
- Bone Biology
- Mineral Metabolism
Background:
- Noncollagenous bone proteins (NCBP) are known to inhibit calcium phosphate precipitation in vitro.
- The in vivo role and relative efficiency of these proteins in regulating bone mineral solubility remain to be fully elucidated.
Purpose of the Study:
- To investigate the in vivo activity and relative efficiency of different NCBP in inhibiting hydroxyapatite growth.
- To characterize the properties of bone proteins involved in calcium phosphate precipitation regulation.
Main Methods:
- Fractionation of NCBP from young adult sheep bones using non-degradative techniques.
- Measurement of relative inhibitory activity by assessing prevention of hydroxyapatite growth.
- Analysis of protein activity on a weight and molecular weight basis.
- Assessment of alkaline phosphatase sensitivity of inhibitory activity.
Main Results:
- On a weight basis, osteocalcin and a phosphorylated protein (similar to osteonectin) showed equal inhibitory activity.
- On a molecular weight basis, the phosphorylated protein exhibited nearly three times the activity of osteocalcin.
- The inhibitory activity of the phosphorylated protein was sensitive to alkaline phosphatase.
Conclusions:
- Both osteocalcin and osteonectin play significant roles in regulating bone mineral solubility.
- Osteonectin is a more potent inhibitor of hydroxyapatite growth on a per-molecule basis.
- The properties of osteonectin suggest a key role in maintaining calcium equilibrium between bone and blood.